Workflow
证券诉讼
icon
搜索文档
SEMLER INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Semler Scientific Investors of the October 28th Deadline and Urges Investors to Contact the Firm
Globenewswire· 2025-10-11 02:26
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Semler Scientific securities between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- What’s Happenin ...
SMLR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
Prnewswire· 2025-10-10 06:55
法律诉讼背景 - 律师事务所Faruqi & Faruqi正在调查针对Semler Scientific的潜在索赔,并提醒投资者关于2025年10月28日的首席原告申请截止日期 [1] - 该联邦证券集体诉讼指控公司及其高管违反了联邦证券法 [2] 涉嫌违规行为 - 指控称公司未披露美国司法部就违反《虚假申报法》对其进行的一项重要调查,却以假设性术语讨论可能的违规行为 [2] - 因此,被告的公开陈述在所有相关时间均存在重大虚假和/或误导性 [2] 事件披露与市场影响 - 公司于2025年2月28日收盘后向美国证券交易委员会提交的2024年10-K年度报告披露,其于2025年2月11日开始了与司法部的初步和解讨论,但当日即中止了讨论 [3] - 年度报告指出存在司法部就民事《虚假申报法》提起诉讼的风险,且公司认为损失金额无法合理估计 [3] - 此消息导致Semler Scientific股价在下一个交易日下跌超过9% [3]
KBR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of KBR
Globenewswire· 2025-10-06 11:39
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Prnewswire· 2025-10-03 22:40
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a ...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive
Prnewswire· 2025-09-24 23:30
Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Unicycive To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Unicycive between March 29, 2024 and June 27, 2025and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). [You may also click here for additional inform ...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Prnewswire· 2025-09-24 22:10
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 Â (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept. ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quantum Corporation
Prnewswire· 2025-09-13 23:05
NEW YORK, Sept. 13, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Quantum Corporation ("Quantum Corporation" or the "Company") (NASDAQ: QMCO) and reminds investors of the November 3, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruqi is a leading national ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fiserv
Prnewswire· 2025-09-07 00:10
公司事件概述 - 律师事务所Faruqi & Faruqi正在调查Fiserv公司并提醒投资者关于针对该公司的联邦证券集体诉讼案 该诉讼的牵头原告申请截止日期为2025年9月22日 [1] - 诉讼指控Fiserv公司及其高管违反了联邦证券法 涉及在2024年7月24日至2025年7月22日期间作出虚假和/或误导性陈述及/或未能披露重要信息 [1][3] 诉讼指控的具体内容 - 指控称Fiserv因其旧版Payeezy平台的成本问题和其他问题 强制Payeezy商户迁移至其Clover平台 [3] - 指控称这些强制转换暂时且不可持续地推高了Clover的收入增长和总支付量 掩盖了新商户业务的放缓 [3] - 指控称在转换后不久 大量前Payeezy商户因Clover的高定价、显著停机时间和系统性兼容性问题而转向竞争解决方案 [3] - 指控称基于上述原因 Clover的GPV增长正在显著放缓 其收入增长不可持续 且Fiserv在诉讼期间关于Clover增长策略、竞争、损耗、GPV增长和业务前景的正面陈述存在重大虚假和误导性 [3] 市场反应与股价影响 - 2025年4月24日 Fiserv报告2025年第一季度Clover的GPV增长仅为8% 较2024年14%至17%的GPV增长率出现实质性下降 公司将此归因于从Payeezy转换至Clover的商户在2025年的交易量较低 此消息导致Fiserv股价下跌18.5% 收于每股176.90美元 [4] - 2025年5月15日 Fiserv披露GPV增长减速将在2025年全年持续 此消息导致股价下跌16.2% 收于每股159.13美元 [4] - 2025年7月23日 Fiserv下调了其全年有机增长指引范围的上限 并确认其商户解决方案部门的季度有机收入同比增长已从上一季度的11%减速至9% 此消息导致股价下跌13.9% 收于每股143.00美元 [4]
马斯克要求驳回美国SEC针对其2022年推特持股提起的诉讼
格隆汇APP· 2025-08-29 11:46
公司动态 - 马斯克提出动议要求驳回美国证交会针对其2022年推特持股提起的诉讼 [1]
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of C3.ai, Inc. Securities and Sets a Lead Plaintiff Deadline of October 21, 2025
GlobeNewswire News Room· 2025-08-23 06:11
诉讼背景 - 针对C3ai公司证券购买者的集体诉讼已提起 涉及2025年2月26日至8月8日期间交易方[1] - 诉讼案件编号为3:25-cv-07129 由美国加州北部地区法院受理[1] 指控内容 - 公司被指控在投资者沟通中发布 materially false and misleading statements[4] - 公司隐瞒首席执行官健康状况对交易达成能力的重大影响[4] - 管理层未能有效减轻首席执行官健康问题带来的运营冲击[4] - 公司实际无法实现其利润和增长潜力[4] 财务表现 - 2025年8月8日公司公布2026财年第一季度初步财务数据 结果令人失望[5] - 公司下调2026整个财年的收入指引[5] - 业绩不佳归因于新领导层重组和首席执行官健康问题[5] 市场反应 - 公告后股价从8月8日22.13美元/股暴跌至8月11日16.47美元/股[6] - 单日跌幅达25.58%[6] - 投资者损失申报截止期为2025年10月21日[6]